NM_000891.3:c.715G>T
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PVS1_StrongPM2PP5_Moderate
The NM_000891.3(KCNJ2):c.715G>T(p.Glu239*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000205 in 1,461,884 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_000891.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461884Hom.: 0 Cov.: 32 AF XY: 0.00000275 AC XY: 2AN XY: 727244
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Andersen Tawil syndrome;C1865018:Short QT syndrome type 3 Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. A different truncation downstream of this variant (p.Ser369*) has been determined to be pathogenic (PMID: 21493816). This suggests that deletion of this region of the KCNJ2 protein is causative of disease. This variant is not present in population databases (ExAC no frequency) and has not been reported in the literature in individuals with a KCNJ2-related disease. This sequence change results in a premature translational stop signal in the last exon of the KCNJ2 mRNA at codon 239 (p.Glu239*). While this is not anticipated to result in nonsense mediated decay, it is expected to delete the last 189 amino acids of the KCNJ2 protein. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at